TY - JOUR
T1 - Inhibition of thrombin attenuates stenosis after arterial injury in minipigs
AU - Abendschein, Dana R.
AU - Recchia, Dino
AU - Meng, Yuan Yuan
AU - Oltrona, Luigi
AU - Wickline, Samuel A.
AU - Eisenberg, Paul R.
N1 - Funding Information:
This study was supported in part by Grant HL-42950 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; by an Established Investigator award (Dr. Wickline) and a Postdoctoral Fellowship (Dr. Recchia) from the American Heart Association, Dallas, Texas; and by a grant from Merck, Sharp and Dohme Laboratories, West Point, Pennsylvania.
PY - 1997/12
Y1 - 1997/12
N2 - Objectives. We sought to determine whether brief, profound inhibition of thrombin or prothrombin activation by factor Xa limits neointimal formation and stenosis after arterial injury. Background. Thrombin has been implicated as a mediator of neointimal formation, but adjunctive administration of anticoagulant agents has not proven effective to decrease restenosis in patients undergoing coronary angioplasty. Methods. We infused recombinant desulfatohirudin (r-hirudin, bolus of 2 mg/kg body weight followed by 2 mg/kg per h, n = 9), heparin (100 U/kg per h, n = 6) or recombinant tick anticoagulant peptide (rTAP, 1-mg/kg bolus followed by 3 mg/kg per h, n = 5), a specific inhibitor of factor Xa, intravenously, beginning 15 min before and for up to 3 h after repetitive balloon hyperinflations sufficient to disrupt the internal elastic lamina in a carotid artery of minipigs with hypercholesterolemia induced by feeding them an atherogenic diet. Results. Partial thromboplastin time was increased six- to sevenfold over baseline levels at the end of the infusions of the anticoagulant agents. Lumen stenosis measured histologically 4 weeks after balloon-induced carotid injury was 29 ± 16% (mean ± SEM) in r-hirudin-treated, 52 ± 19% in rTAP-treated and 76 ± 18% in heparin-treated pigs (p < 0.02 for r-hirudin vs. heparin treatment). Conclusions. The marked reduction of stenosis in r-hirudin-treated animals indicates that thrombin plays a major role in neointimal formation after balloon-induced arterial injury. A relatively brief interval of profound, direct inhibition of thrombin may be particularly effective to attenuate restenosis after balloon angioplasty.
AB - Objectives. We sought to determine whether brief, profound inhibition of thrombin or prothrombin activation by factor Xa limits neointimal formation and stenosis after arterial injury. Background. Thrombin has been implicated as a mediator of neointimal formation, but adjunctive administration of anticoagulant agents has not proven effective to decrease restenosis in patients undergoing coronary angioplasty. Methods. We infused recombinant desulfatohirudin (r-hirudin, bolus of 2 mg/kg body weight followed by 2 mg/kg per h, n = 9), heparin (100 U/kg per h, n = 6) or recombinant tick anticoagulant peptide (rTAP, 1-mg/kg bolus followed by 3 mg/kg per h, n = 5), a specific inhibitor of factor Xa, intravenously, beginning 15 min before and for up to 3 h after repetitive balloon hyperinflations sufficient to disrupt the internal elastic lamina in a carotid artery of minipigs with hypercholesterolemia induced by feeding them an atherogenic diet. Results. Partial thromboplastin time was increased six- to sevenfold over baseline levels at the end of the infusions of the anticoagulant agents. Lumen stenosis measured histologically 4 weeks after balloon-induced carotid injury was 29 ± 16% (mean ± SEM) in r-hirudin-treated, 52 ± 19% in rTAP-treated and 76 ± 18% in heparin-treated pigs (p < 0.02 for r-hirudin vs. heparin treatment). Conclusions. The marked reduction of stenosis in r-hirudin-treated animals indicates that thrombin plays a major role in neointimal formation after balloon-induced arterial injury. A relatively brief interval of profound, direct inhibition of thrombin may be particularly effective to attenuate restenosis after balloon angioplasty.
UR - http://www.scopus.com/inward/record.url?scp=0030473882&partnerID=8YFLogxK
U2 - 10.1016/S0735-1097(96)00362-2
DO - 10.1016/S0735-1097(96)00362-2
M3 - Article
C2 - 8962575
AN - SCOPUS:0030473882
SN - 0735-1097
VL - 28
SP - 1849
EP - 1855
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 7
ER -